Mucosal melanoma frequently harbors atypical BRAF mutations other than the p.V600 hot spot (such as p.G469A, p.L597Q, p.N581S, p.T599I, and p.G596R), rendering BRAF inhibitors that revolutionized melanoma treatment not applicable in this population [28]. The gene discussed is BRAF; the disease is melanoma.